Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05036096 · ClinicalTrials.gov registry record · NA
Cone Beam Breast CT for Breast Cancer Screening
A NA study of Breast Cancer, sponsored by Koning Corporation.
- Active
- Registry status
- NA
- Development phase
- 1,024
- Enrollment target
- 4
- Study locations
NCT05036096: Active NA study of Breast Cancer, sponsored by Koning Corporation.
NCT05036096 is a NA study of Breast Cancer that is active but no longer recruiting, run by Koning Corporation. The registered enrollment target is 1,024 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (63% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05036096, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by Koning Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,024 participants
- Enrollment target
- 4
- Study locations
Study Summary
Up to one thousand and twenty-eight (1028) patients from screening and diagnostic population will be enrolled and consented to participate in the study to create an enriched data set. These women will be enrolled from annual screening population and diagnostic workup population. The enrolled patient will undergo KBCT scans within 4 weeks of her screening or diagnostic mammography exam and before breast biopsy occurs if biopsy is needed.
Conditions Studied
Interventions
- DEVICE CBBCT Imaging
- DEVICE Digital Mammography
Study Locations (4)
Georgia
- Women's Imaging Specialists - Dacula
- The Howard Center for Women's Health - Tifton
Florida
- Port Orange Imaging Center - Port Orange
Tennessee
- Knoxville Comprehensive Breast Center - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,024 participants |
| Start Date | 2021-10-30 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05036096
The ClinicalTrials.gov registry entry for NCT05036096 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,024 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (63% lower). The listed sponsor is Koning Corporation, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which CBBCT Imaging is the first listed.
NCT05036096 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Georgia, Florida, Tennessee.
Frequently Asked Questions
What is clinical trial NCT05036096 about?
NCT05036096 is a clinical study titled "Cone Beam Breast CT for Breast Cancer Screening". Up to one thousand and twenty-eight (1028) patients from screening and diagnostic population will be enrolled and consented to participate in the study to create an enriched data set. These women will be enrolled from annual screening population and diagnostic workup population. The enrolled patient...
What is the current status of trial NCT05036096?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,024 participants. The study started on 2021-10-30. Estimated completion is 2026-12-30.
What conditions does trial NCT05036096 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT05036096?
The interventions under investigation include: CBBCT Imaging (DEVICE), Digital Mammography (DEVICE).
Who is sponsoring clinical trial NCT05036096?
This trial is sponsored by Koning Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05036096 being conducted?
This trial has 4 study locations across Florida, Georgia, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.